Title

Topical Ether and Herpes Simplex Labialis

Document Type

Article

Publication Date

3-1980

Publication Title

Journal of the American Medical Association

Volume

243

Issue

10

First page number:

1059

Last page number:

1061

Abstract

In a double-blind, placebo-controlled study, 51 patients with recurrent herpes simplex labialis were treated with topical ether or placebo within 24 hours of onset of a lesion. There was no noteworthy difference between groups given ether and placebo in progression of lesions, healing time, duration or intensity of pain, and duration or quantity of virus excretion. The ether also failed to reduce appreciably lesion virus titer, even when lesions were cultured immediately after topical application. Despite these results, 75% of the patients receiving ether and 77% of those receiving placebo reported effective reduction of the severity and duration of lesions. The marked placebo effect in the treatment of recurrent herpes infection helps to emphasize the need for objective measurements and placebo-controlled studies.

Keywords

Ether; Herpes simplex virus – Treatment; Placebos (Medicine)

Disciplines

Investigative Techniques | Virus Diseases

Language

English

Permissions

Use Find in Your Library, contact the author, or use interlibrary loan to garner a copy of the article. Publisher copyright policy allows author to archive post-print (author’s final manuscript). When post-print is available or publisher policy changes, the article will be deposited


Search your library

Share

COinS